Preeti Shanbag1. 1. Department of Pediatrics, ESI Post Graduate Institute of Medical Sciences and Research, Mahatma Gandhi Memorial Hospital, Parel, Mumbai, Maharashtra, India.
Sir,I read with interest the article “Metabolic alkalosis: A less appreciated side effect of Imipenem-cilastin use” by Panda and colleagues in the July–August issue of the journal.[1] Ironically, the authors substituted imipenem-cilastin with piperacillin-tazobactum which has also been reported to be associated with hypokalemia and metabolic alkalosis by a similar mechanism.[23]